A 2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on
2022/05/15 by Chrysoula Boutari, Christos S. Mantzoros · 1,045 citations
Health Professions · Medicine · #Cardiovascular Disease and Adiposity #Coronavirus disease 2019 (COVID-19) #Demography #Disease #Environmental health #Epidemiology #Gerontology #Infectious disease (medical specialty) #Internal medicine #Medicine #Obesity #Obesity and Health Practices #Obesity, Physical Activity, Diet #Overweight #Pandemic #Pathology #Public health #Sociology
paper · pdf · doi:10.1016/j.metabol.2022.155217
published in Metabolism 133, 155217 (Elsevier BV)
openalex publication_date 2022/05/15 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/05
Abstract
The WHO just released in May 2022 a report on the state of the obesity pandemic in Europe, stating that 60% of citizens in the area of Europe are either overweight or obese, and highlighting the implications of the obesity pandemic, especially as it interacts with the COVID pandemic to create a twin pandemic, to increase morbidity and mortality. Obesity is a complex disease which has reached pandemic dimensions. The worldwide prevalence of obesity has nearly tripled since 1975, mainly due to the adoption of a progressively more sedentary lifestyle and the consumption of less healthy diets. We first report herein updated prevalence rates of overweight and obesity by sex, age, and region first in Europe, per the WHO report, and then worldwide between 1980 and 2019, as we analyze and present herein the data provided by the Global Burden of Disease Study. The prevalence of obesity is higher in women than in men of any age and the prevalence of both overweight and obesity increases with age and has reached their highest point between the ages of 50 to 65 years showing a slight downward trend afterwards. The age-standardized prevalence of obesity has increased from 4.6% in 1980 to 14.0% in 2019. The American and European region have the highest obesity prevalence and the USA and Russia are the countries with the most obese residents. Given dire implications in terms of comorbidities and mortality, these updated epidemiological findings call for coordinated actions from local and regional governments, the scientific community and individual patients alike, as well as the food industry for the obesity pandemic to be controlled and alleviated. We can hopefully learn from the COVID-19 pandemic, where collaborative efforts worldwide, focused intense work at both the local and global level and well-coordinated leadership have demonstrated that humankind is capable of amazing accomplishments by leveraging science and public health, and that we can finally make strides in terms of understanding and combating the obesity pandemic and its dire comorbidities including diabetes, NAFLD, CVD and obesity associated malignancies.
Citations
Cited by
- The Therapeutic Potential of Theobromine in Obesity: A Comprehensive Review
- Emerging pharmacotherapies for obesity: A systematic review
- Isotemporal substitution of sedentary time with physical activity and sleeping time: associations with body composition among individuals with prediabetes
- The relationship between obesity and chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
- The association of a polygenic lifespan score with the risk of common age-related diseases and mortality
- Obesity duration is linked to bariatric surgery outcomes via adipose tissue response
- Durian husk-mediated green synthesis of Cr 2 O 3 nanoparticles exhibiting uncompetitive inhibition of pancreatic lipase for anti-obesity applications
- Unraveling the Molecular Mechanisms of ABHD5 Membrane Targeting
- Green-synthesized chromium oxide nanoparticles using pomegranate husk extract: Multifunctional bioactivity in antioxidant potential, lipase and amylase inhibition, and cytotoxicity
- Obesogens: a unifying theory for the global rise in obesity
- Point-of-choice kilocalorie labelling practices in large, out-of-home food businesses: a preobservational versus post observational study of labelling practices following implementation of The Calorie Labelling (Out of Home Sector) (England) Regulations 2021
- Obesity and Comorbidity Management in Psoriatic Arthritis
- Transcriptional and post-transcriptional control of autophagy and adipogenesis by YBX1. [europepmc]
- Microbiome Dysbiosis: A Pathological Mechanism at the Intersection of Obesity and Glaucoma. [europepmc]
- Enhancing intestinal barrier efficiency: A novel metabolic diseases therapy. [europepmc]
- Obesity and Cardiovascular Risk: Systematic Intervention Is the Key for Prevention. [europepmc]
- The Influence of Dietary Interventions on Arterial Stiffness in Overweight and Obese Subjects. [europepmc]
- Understanding the Changing Landscape of Health Disparities in Chronic Liver Diseases and Liver Cancer. [europepmc]
- Effects of miR-33 Deficiency on Metabolic and Cardiovascular Diseases: Implications for Therapeutic Intervention. [europepmc]
- Gender Differences in the Pathogenesis and Risk Factors of Hepatocellular Carcinoma. [europepmc]
- System inflammation response index: a novel inflammatory indicator to predict all-cause and cardiovascular disease mortality in the obese population. [europepmc]
- Fatty Liver Index (FLI) Identifies Not Only Individuals with Liver Steatosis but Also at High Cardiometabolic Risk. [europepmc]
- Muscle fiber phenotype: a culprit of abnormal metabolism and function in skeletal muscle of humans with obesity. [europepmc]
- Lipid overload-induced RTN3 activation leads to cardiac dysfunction by promoting lipid droplet biogenesis. [europepmc]
- The Characteristics, Mechanisms and Therapeutics: Exploring the Role of Gut Microbiota in Obesity. [europepmc]
- Subclinical Hypothyroidism in Patients with Obesity and Metabolic Syndrome: A Narrative Review. [europepmc]
- Obesogens: a unifying theory for the global rise in obesity. [europepmc]
- Integrating network pharmacology and animal experimental validation to investigate the action mechanism of oleanolic acid in obesity. [europepmc]
- Is ChatGPT an Effective Tool for Providing Dietary Advice? [europepmc]
- Effects of combined dietary intervention and physical-cognitive exercise on cognitive function and cardiometabolic health of postmenopausal women with obesity: a randomized controlled trial. [europepmc]
- Associations of trajectories in body roundness index with incident cardiovascular disease: a prospective cohort study in rural China. [europepmc]
- 2023 Obesity Fact Sheet: Prevalence of Obesity and Abdominal Obesity in Adults, Adolescents, and Children in Korea from 2012 to 2021. [europepmc]
- Therapeutic advances in obesity management: an overview of the therapeutic interventions. [europepmc]
- Mediterranean diet in the targeted prevention and personalized treatment of chronic diseases: evidence, potential mechanisms, and prospects. [europepmc]
- Beyond Calories: Individual Metabolic and Hormonal Adaptations Driving Variability in Weight Management-A State-of-the-Art Narrative Review. [europepmc]
- Sex-specific risk factors for new-onset heart failure: the PREVEND study at 25 years. [europepmc]
- Obesity: Prevalence, causes, consequences, management, preventive strategies and future research directions. [europepmc]
Related